AI-Based Video Analysis for Motor Development Assessment in Children

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5-10
SponsorMedipol University

About this trial

This is a non-interventional, prospective observational study aimed at developing and validating an artificial intelligence-based system for assessing motor development in children using video analysis. Children aged 5 to 10 years will perform standardized motor tasks, which will be recorded under controlled conditions. The recorded videos will be analyzed using computer vision and deep learning techniques to extract movement patterns.

The results of the AI-based analysis will be compared with standardized motor assessment scores obtained from the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition - Short Form (BOT-2 SF). Participants will be classified into typical and atypical motor development groups based on BOT-2 scores. The primary objective is to evaluate the classification performance of the AI model. Secondary analyses will examine the relationship between AI predictions and continuous motor performance scores.

The study is designed to explore whether motor development can be assessed objectively without direct clinical testing, using only short video recordings. The findings may contribute to the development of scalable and accessible digital screening tools for early identification of motor development differences in children.

Eligibility criteria

Qualifiers

Children aged between 5 and 10 years

No diagnosed neurological, developmental, or orthopedic disorders

Ability to follow verbal instructions

Informed consent obtained from parents or legal guardians

Disqualifiers

Diagnosed neurological, developmental, or orthopedic conditions (e.g., autism spectrum disorder, cerebral palsy, epilepsy)

Visual or hearing impairments affecting task performance

Severe attention or behavioral problems preventing test completion

Physical limitations preventing participation in motor tasks

Trial design

Treatments tested in this trial

  • Observational Assessment Only

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators